Interestingly, this lncRNA acts as a glucocorticoid receptor inhibitor [14], and its increase following therapy, as reported by our data, corroborates the hypothesis that increased glucocorticoid levels underlie neuronal and glial dysfunction in BD [15]. Here, NR3C1 is linked to Behcet disease.